AposTherapy is an innovative, FDA cleared treatment for knee osteoarthritis and qualifies as a wellness device for use with other musculoskeletal conditions such as lower back pain. AposTherapy works on biomechanical and neuromuscular levels, combining a foot-worn patented medical device with a treatment program. The treatment addresses the underlying causes of pain by shifting pressure away from painful areas and providing a long-lasting neuromuscular effect by re-educating muscles to a healthier walking pattern, even when not wearing the device.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/18/20 | $11,000,000 | Series A Extension |
aMoon | undisclosed |
